Organization
MedImmune LLC
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
MedImmune LLC
... Biogen Inc, Evotec AG, Genmab A/S, H. Lundbeck A/S, ICB International Inc, MedImmune LLC, Neuropore Therapies Inc, nLife Therapeutics SL, Prothena Corp Plc, QR Pharma ...
... Enzo Life Sciences (US), Master Diagnóstica (Spain), TissueGnostics (Austria), Bio SB (US), MedImmune (US), Cernostics (US), Zenalux Biomedical (US), 3DHISTECH (Hungary), Lunaphore Technologies (Switzerland), BioGenex ...
... the ESMO Asia 2017 Congress in Singapore, 17-19 November 2017, AstraZeneca and MedImmune, its global biologics research and development arm, will share ground-breaking results from ...
... AstraZeneca(NYSE: AZN) and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has approved ...
... for the region. Thought leaders from the National Institutes of Health (NIH), MedImmune , Vibrent Health , Virginia Tech , the National Science Foundation (NSF), ...
... 2, S. Althammer 1, R. Huss 1 1 Definiens, Munich, Germany; 2 MedImmune, Gaithersburg MD, USA Friday, Nov. 10: 12:30 - 2 p.m. (Lunch) Friday, ...
... caused by human papillomavirus (HPV) types 16 and 18 and licensed to MedImmune, the global Research and Development arm of AstraZeneca, also led to a ...
... AstraZeneca and MedImmune, its global biologics research and development arm, will be underlining its scientific ...
... HPV-Related Head & Neck Cancer (Phase 1/2) In May, Inovio announced that MedImmune, AstraZeneca's global biologics research and development arm, commenced a new clinical trial ...
... AstraZeneca and its global biologics research and development arm, MedImmune, today announced the top-line results of the Phase III STRATOS 2 and ...
... AstraZeneca and Medimmune, its global biologics research and development arm, continue to demonstrate their progress ...
... AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US ...
... AstraZeneca, along with MedImmune, its global biologics research and development arm, has announced that the European ...
... Board Members: Kathleen L. Coelingh, Ph.D. was Senior Director, Medical Affairs at MedImmune, the biologics unit of AstraZeneca. Prior to that while at the NIH ...
... AstraZeneca and MedImmune, its global biologics research and development arm, have presented the full PFS ...
... with three different PD-1/PDL-1 immuno-oncology combo efficacy studies with 3 different collaborators MedImmune, Regeneron, and Genentech for MEDI0457 and INO-5401." INO-5150, an active immunotherapy targeting ...
... AstraZeneca and MedImmune, its global biologics research and development arm, today announced the full progression-free ...
... AstraZeneca and its global biologics research and development arm, MedImmune, will present new data on its respiratory portfolio and pipeline at the ...
... research collaboration with AstraZeneca and its global biologics research and development arm, MedImmune. The collaboration is focused on developing new stabilised non-immunogenic modified RNA therapies ...
... from higher revenue recognized related to Inovio's license and collaboration agreement with MedImmune entered into in 2015. The increase in revenue was primarily due to ...
... from higher revenue recognized related to Inovio's license and collaboration agreement with MedImmune entered into in 2015. The increase in revenue was primarily due to ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤